1
|
Wang L. Deep Learning Techniques to Diagnose Lung Cancer. Cancers (Basel) 2022; 14:cancers14225569. [PMID: 36428662 PMCID: PMC9688236 DOI: 10.3390/cancers14225569] [Citation(s) in RCA: 22] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Revised: 11/11/2022] [Accepted: 11/11/2022] [Indexed: 11/15/2022] Open
Abstract
Medical imaging tools are essential in early-stage lung cancer diagnostics and the monitoring of lung cancer during treatment. Various medical imaging modalities, such as chest X-ray, magnetic resonance imaging, positron emission tomography, computed tomography, and molecular imaging techniques, have been extensively studied for lung cancer detection. These techniques have some limitations, including not classifying cancer images automatically, which is unsuitable for patients with other pathologies. It is urgently necessary to develop a sensitive and accurate approach to the early diagnosis of lung cancer. Deep learning is one of the fastest-growing topics in medical imaging, with rapidly emerging applications spanning medical image-based and textural data modalities. With the help of deep learning-based medical imaging tools, clinicians can detect and classify lung nodules more accurately and quickly. This paper presents the recent development of deep learning-based imaging techniques for early lung cancer detection.
Collapse
Affiliation(s)
- Lulu Wang
- Biomedical Device Innovation Center, Shenzhen Technology University, Shenzhen 518118, China
| |
Collapse
|
2
|
Balasch A, Metze P, Li H, Rottbauer W, Abaei A, Rasche V. Tiny golden angle ultrashort echo-time lung imaging in mice. NMR IN BIOMEDICINE 2021; 34:e4591. [PMID: 34322941 DOI: 10.1002/nbm.4591] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/09/2020] [Revised: 06/25/2021] [Accepted: 07/04/2021] [Indexed: 06/13/2023]
Abstract
Imaging the lung parenchyma with MRI is particularly difficult in small animals due to the high respiratory and heart rates, and ultrashort T2* at high magnetic field strength caused by the high susceptibilities induced by the air-tissue interfaces. In this study, a 2D ultrashort echo-time (UTE) technique was combined with tiny golden angle (tyGA) ordering. Data were acquired continuously at 11.7 T and retrospective center-of-k-space gating was applied to reconstruct respiratory multistage images. Lung (proton) density (fP ), T2*, signal-to-noise ratio (SNR), fractional ventilation (FV) and perfusion (f) were quantified, and the application to dynamic contrast agent (CA)-enhanced (DCE) qualitative perfusion assessment tested. The interobserver and intraobserver and interstudy reproducibility of the quantitative parameters were investigated. High-quality images of the lung parenchyma could be acquired in all animals. Over all lung regions a mean T2* of 0.20 ± 0.05 ms was observed. FV resulted as 0.31 ± 0.13, and a trend towards lower SNR values during inspiration (EX: SNR = 12.48 ± 6.68, IN: SNR = 11.79 ± 5.86) and a significant (P < 0.001) decrease in lung density (EX: fP = 0.69 ± 0.13, IN: fP = 0.62 ± 0.13) were observed. Quantitative perfusion results as 34.63 ± 9.05 mL/cm3 /min (systole) and 32.77 ± 8.55 mL/cm3 /min (diastole) on average. The CA dynamics could be assessed and, because of the continuous nature of the data acquisition, reconstructed at different temporal resolutions. Where a good to excellent interobserver reproducibility and an excellent intraobserver reproducibility resulted, the interstudy reproducibility was only fair to good. In conclusion, the combination of tiny golden angles with UTE (2D tyGA UTE) resulted in a reliable imaging technique for lung morphology and function in mice, providing uniform k-space coverage and thus low-artefact images of the lung parenchyma after gating.
Collapse
Affiliation(s)
- Anke Balasch
- Department of Internal Medicine II, Ulm University Medical Centre, Ulm, Germany
| | - Patrick Metze
- Department of Internal Medicine II, Ulm University Medical Centre, Ulm, Germany
| | - Hao Li
- Department of Cardiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Cardiac Electrophysiology and Arrhythmia, People's Republic of China
- Core Facility Small Animal Imaging (CF-SANI), Ulm University, Ulm, Germany
| | - Wolfgang Rottbauer
- Department of Internal Medicine II, Ulm University Medical Centre, Ulm, Germany
| | - Alireza Abaei
- Core Facility Small Animal Imaging (CF-SANI), Ulm University, Ulm, Germany
| | - Volker Rasche
- Department of Internal Medicine II, Ulm University Medical Centre, Ulm, Germany
- Core Facility Small Animal Imaging (CF-SANI), Ulm University, Ulm, Germany
| |
Collapse
|
3
|
Stecker IR, Freeman MS, Sitaraman S, Hall CS, Niedbalski PJ, Hendricks AJ, Martin EP, Weaver TE, Cleveland ZI. Preclinical MRI to Quantify Pulmonary Disease Severity and Trajectories in Poorly Characterized Mouse Models: A Pedagogical Example Using Data from Novel Transgenic Models of Lung Fibrosis. JOURNAL OF MAGNETIC RESONANCE OPEN 2021; 6-7. [PMID: 34414381 PMCID: PMC8372031 DOI: 10.1016/j.jmro.2021.100013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/09/2023]
Abstract
Structural remodeling in lung disease is progressive and heterogeneous, making temporally and spatially explicit information necessary to understand disease initiation and progression. While mouse models are essential to elucidate mechanistic pathways underlying disease, the experimental tools commonly available to quantify lung disease burden are typically invasive (e.g., histology). This necessitates large cross-sectional studies with terminal endpoints, which increases experimental complexity and expense. Alternatively, magnetic resonance imaging (MRI) provides information noninvasively, thus permitting robust, repeated-measures statistics. Although lung MRI is challenging due to low tissue density and rapid apparent transverse relaxation (T2* <1 ms), various imaging methods have been proposed to quantify disease burden. However, there are no widely accepted strategies for preclinical lung MRI. As such, it can be difficult for researchers who lack lung imaging expertise to design experimental protocols-particularly for novel mouse models. Here, we build upon prior work from several research groups to describe a widely applicable acquisition and analysis pipeline that can be implemented without prior preclinical pulmonary MRI experience. Our approach utilizes 3D radial ultrashort echo time (UTE) MRI with retrospective gating and lung segmentation is facilitated with a deep-learning algorithm. This pipeline was deployed to assess disease dynamics over 255 days in novel, transgenic mouse models of lung fibrosis based on disease-associated, loss-of-function mutations in Surfactant Protein-C. Previously identified imaging biomarkers (tidal volume, signal coefficient of variation, etc.) were calculated semi-automatically from these data, with an objectively-defined high signal volume identified as the most robust metric. Beyond quantifying disease dynamics, we discuss common pitfalls encountered in preclinical lung MRI and present systematic approaches to identify and mitigate these challenges. While the experimental results and specific pedagogical examples are confined to lung fibrosis, the tools and approaches presented should be broadly useful to quantify structural lung disease in a wide range of mouse models.
Collapse
Affiliation(s)
- Ian R Stecker
- Department of Biomedical Engineering, University of Cincinnati, Cincinnati, OH 45221
- Center for Pulmonary Imaging Research, Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229
| | - Matthew S Freeman
- Center for Pulmonary Imaging Research, Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229
| | - Sneha Sitaraman
- Division of Neonatology and Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229
| | - Chase S Hall
- Division of Pulmonary and Critical Care, University of Kansas Medical Center, Kansas City, KS 66160
| | - Peter J Niedbalski
- Center for Pulmonary Imaging Research, Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229
- Division of Pulmonary and Critical Care, University of Kansas Medical Center, Kansas City, KS 66160
| | - Alexandra J Hendricks
- Department of Biomedical Engineering, University of Cincinnati, Cincinnati, OH 45221
- Center for Pulmonary Imaging Research, Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229
| | - Emily P Martin
- Division of Neonatology and Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229
| | - Timothy E Weaver
- Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45221
- Division of Neonatology and Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229
| | - Zackary I Cleveland
- Department of Biomedical Engineering, University of Cincinnati, Cincinnati, OH 45221
- Center for Pulmonary Imaging Research, Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229
- Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45221
| |
Collapse
|
4
|
Tielemans B, Dekoster K, Verleden SE, Sawall S, Leszczyński B, Laperre K, Vanstapel A, Verschakelen J, Kachelriess M, Verbeken E, Swoger J, Vande Velde G. From Mouse to Man and Back: Closing the Correlation Gap between Imaging and Histopathology for Lung Diseases. Diagnostics (Basel) 2020; 10:E636. [PMID: 32859103 PMCID: PMC7554749 DOI: 10.3390/diagnostics10090636] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Revised: 08/21/2020] [Accepted: 08/24/2020] [Indexed: 02/07/2023] Open
Abstract
Lung diseases such as fibrosis, asthma, cystic fibrosis, infection and cancer are life-threatening conditions that slowly deteriorate quality of life and for which our diagnostic power is high, but our knowledge on etiology and/or effective treatment options still contains important gaps. In the context of day-to-day practice, clinical and preclinical studies, clinicians and basic researchers team up and continuously strive to increase insights into lung disease progression, diagnostic and treatment options. To unravel disease processes and to test novel therapeutic approaches, investigators typically rely on end-stage procedures such as serum analysis, cyto-/chemokine profiles and selective tissue histology from animal models. These techniques are useful but provide only a snapshot of disease processes that are essentially dynamic in time and space. Technology allowing evaluation of live animals repeatedly is indispensable to gain a better insight into the dynamics of lung disease progression and treatment effects. Computed tomography (CT) is a clinical diagnostic imaging technique that can have enormous benefits in a research context too. Yet, the implementation of imaging techniques in laboratories lags behind. In this review we want to showcase the integrated approaches and novel developments in imaging, lung functional testing and pathological techniques that are used to assess, diagnose, quantify and treat lung disease and that may be employed in research on patients and animals. Imaging approaches result in often novel anatomical and functional biomarkers, resulting in many advantages, such as better insight in disease progression and a reduction in the numbers of animals necessary. We here showcase integrated assessment of lung disease with imaging and histopathological technologies, applied to the example of lung fibrosis. Better integration of clinical and preclinical imaging technologies with pathology will ultimately result in improved clinical translation of (therapy) study results.
Collapse
Affiliation(s)
- Birger Tielemans
- Department of Imaging and Pathology, KU Leuven, University of Leuven, 3000 Leuven, Belgium; (B.T.); (K.D.); (J.V.); (E.V.)
| | - Kaat Dekoster
- Department of Imaging and Pathology, KU Leuven, University of Leuven, 3000 Leuven, Belgium; (B.T.); (K.D.); (J.V.); (E.V.)
| | - Stijn E. Verleden
- Department of CHROMETA, BREATHE lab, KU Leuven, 3000 Leuven, Belgium; (S.E.V.); (A.V.)
| | - Stefan Sawall
- German Cancer Research Center (DKFZ), X-Ray Imaging and CT, Heidelberg University, 69117 Heidelberg, Germany; (S.S.); (M.K.)
| | - Bartosz Leszczyński
- Department of Medical Physics, M. Smoluchowski Institute of Physics, Faculty of Physics, Astronomy and Applied Computer Science, Jagiellonian University, 31-007 Kraków, Poland;
| | | | - Arno Vanstapel
- Department of CHROMETA, BREATHE lab, KU Leuven, 3000 Leuven, Belgium; (S.E.V.); (A.V.)
| | - Johny Verschakelen
- Department of Imaging and Pathology, KU Leuven, University of Leuven, 3000 Leuven, Belgium; (B.T.); (K.D.); (J.V.); (E.V.)
| | - Marc Kachelriess
- German Cancer Research Center (DKFZ), X-Ray Imaging and CT, Heidelberg University, 69117 Heidelberg, Germany; (S.S.); (M.K.)
| | - Erik Verbeken
- Department of Imaging and Pathology, KU Leuven, University of Leuven, 3000 Leuven, Belgium; (B.T.); (K.D.); (J.V.); (E.V.)
| | - Jim Swoger
- European Molecular Biology Laboratory (EMBL) Barcelona, 08003 Barcelona, Spain;
| | - Greetje Vande Velde
- Department of Imaging and Pathology, KU Leuven, University of Leuven, 3000 Leuven, Belgium; (B.T.); (K.D.); (J.V.); (E.V.)
| |
Collapse
|
5
|
Thakur A, Rose F, Ansari SR, Koch P, Martini V, Ovesen SL, Quistorff B, Maritim S, Hyder F, Andersen P, Christensen D, Mori Y, Foged C. Design of Gadoteridol-Loaded Cationic Liposomal Adjuvant CAF01 for MRI of Lung Deposition of Intrapulmonary Administered Particles. Mol Pharm 2019; 16:4725-4737. [PMID: 31539263 DOI: 10.1021/acs.molpharmaceut.9b00908] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Designing effective and safe tuberculosis (TB) subunit vaccines for inhalation requires identification of appropriate antigens and adjuvants and definition of the specific areas to target in the lungs. Magnetic resonance imaging (MRI) enables high spatial resolution, but real-time anatomical and functional MRI of lungs is challenging. Here, we describe the design of a novel gadoteridol-loaded cationic adjuvant formulation 01 (CAF01) for MRI-guided vaccine delivery of the clinically tested TB subunit vaccine candidate H56/CAF01. Gadoteridol-loaded CAF01 liposomes were engineered by using a quality-by-design approach to (i) increase the mechanistic understanding of formulation factors governing the loading of gadoteridol and (ii) maximize the loading of gadoteridol in CAF01, which was confirmed by cryotransmission electron microscopy. The encapsulation efficiency and loading of gadoteridol were highly dependent on the buffer pH due to strong attractive electrostatic interactions between gadoteridol and the cationic lipid component. Optimal gadoteridol loading of CAF01 liposomes showed good in vivo stability and safety upon intrapulmonary administration into mice while generating 1.5-fold MRI signal enhancement associated with approximately 30% T1 relaxation change. This formulation principle and imaging approach can potentially be used for other mucosal nanoparticle-based formulations, species, and lung pathologies, which can readily be translated for clinical use.
Collapse
Affiliation(s)
- Aneesh Thakur
- Department of Pharmacy, Faculty of Health and Medical Sciences , University of Copenhagen , Universitetsparken 2 , DK-2100 Copenhagen Ø, Denmark
| | - Fabrice Rose
- Department of Pharmacy, Faculty of Health and Medical Sciences , University of Copenhagen , Universitetsparken 2 , DK-2100 Copenhagen Ø, Denmark
| | - Shaquib Rahman Ansari
- Department of Pharmacy, Faculty of Health and Medical Sciences , University of Copenhagen , Universitetsparken 2 , DK-2100 Copenhagen Ø, Denmark
| | - Palle Koch
- Department of Biomedical Sciences, Faculty of Health and Medical Sciences , University of Copenhagen , Blegdamsvej 3 , DK-2200 Copenhagen N, Denmark.,Panum NMR Core Facility , University of Copenhagen , Blegdamsvej 3B , 2200 Copenhagen N, Denmark
| | - Veronica Martini
- Department of Pharmacy, Faculty of Health and Medical Sciences , University of Copenhagen , Universitetsparken 2 , DK-2100 Copenhagen Ø, Denmark
| | - Sofie Lillelund Ovesen
- Department of Pharmacy, Faculty of Health and Medical Sciences , University of Copenhagen , Universitetsparken 2 , DK-2100 Copenhagen Ø, Denmark
| | - Bjørn Quistorff
- Department of Biomedical Sciences, Faculty of Health and Medical Sciences , University of Copenhagen , Blegdamsvej 3 , DK-2200 Copenhagen N, Denmark
| | - Samuel Maritim
- Department of Biomedical Engineering and Magnetic Resonance Research Center , Yale University , 300 Cedar Street , New Haven , Connecticut 06520 , United States
| | - Fahmeed Hyder
- Department of Biomedical Engineering and Magnetic Resonance Research Center , Yale University , 300 Cedar Street , New Haven , Connecticut 06520 , United States
| | - Peter Andersen
- Department of Infectious Disease Immunology , Statens Serum Institut , Artillerivej 5 , 2300 Copenhagen S, Denmark
| | - Dennis Christensen
- Department of Infectious Disease Immunology , Statens Serum Institut , Artillerivej 5 , 2300 Copenhagen S, Denmark
| | - Yuki Mori
- Panum NMR Core Facility , University of Copenhagen , Blegdamsvej 3B , 2200 Copenhagen N, Denmark.,Center for Translational Neuromedicine, Faculty of Health and Medical Sciences , University of Copenhagen , Blegdamsvej 3B , DK-2200 Copenhagen N, Denmark
| | - Camilla Foged
- Department of Pharmacy, Faculty of Health and Medical Sciences , University of Copenhagen , Universitetsparken 2 , DK-2100 Copenhagen Ø, Denmark
| |
Collapse
|
6
|
Bianchi A, Gobbo OL, Dufort S, Sancey L, Lux F, Tillement O, Coll JL, Crémillieux Y. Orotracheal manganese-enhanced MRI (MEMRI): An effective approach for lung tumor detection. NMR IN BIOMEDICINE 2017; 30:e3790. [PMID: 28857310 DOI: 10.1002/nbm.3790] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/18/2016] [Revised: 07/15/2017] [Accepted: 07/19/2017] [Indexed: 06/07/2023]
Abstract
Lung cancer is a primary cause of cancer deaths worldwide. Timely detection of this pathology is necessary to delay or interrupt lung cancer progression, ultimately resulting in a possible better prognosis for the patient. In this context, magnetic resonance imaging (MRI) is especially promising. Ultra-short echo time (UTE) MRI sequences, in combination with gadolinium-based contrast agents, have indeed shown to be especially adapted to the detection of lung neoplastic lesions at submillimeter precision. Manganese-enhanced MRI (MEMRI) increasingly appears to be a possible effective alternative to gadolinium-enhanced MRI. In this work, we investigated whether low-dose MEMRI can effectively target non-small-cell lung cancer in rodents, whilst minimizing the potential toxic effect of manganese. Both systemic and orotracheal administration modalities allowed the identification of tumors of submillimeter size, as confirmed by bioluminescence imaging and histology. Equivalent tumor signal enhancements and contrast-to-noise ratios were observed with orotracheal administration using 20 times lower doses compared with the more conventional systemic route. This finding is of crucial importance as it supports the observation that higher performances of contrast agents can be obtained using an orotracheal administration route when targeting lung diseases. As a consequence, lower concentrations of contrast media can be employed, reducing the dose and potential safety issues. The non-detectable accumulation of ionic manganese in the brain and liver following orotracheal administration observed in vivo is extremely encouraging with regard to the safety of the orotracheal protocol with low-dose Mn2+ administration. To our knowledge, this is the first time that a study has clearly allowed the high-precision detection of lung tumor and its contours via the synergic employment of a strongly T1 -weighted MRI UTE sequence and ionic manganese, an inexpensive contrast agent. Overall, these results support the growing interest in drug and contrast agent delivery via the airways to target and diagnose several diseases of the lungs.
Collapse
Affiliation(s)
- Andrea Bianchi
- Centre de Résonance Magnétique des Systèmes Biologiques,CNRS UMR 5536, Université Bordeaux, Bordeaux, France
| | - Oliviero L Gobbo
- School of Pharmacy and Pharmaceutical Sciences and Institute of Neuroscience, Trinity College Dublin, Ireland
| | - Sandrine Dufort
- Nano-H S.A.S, Saint Quentin-Fallavier, France
- Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France
| | - Lucie Sancey
- Univ Lyon, Université Claude Bernard Lyon 1, CNRS, Institut Lumiére Matiére, Lyon, France
| | - François Lux
- Univ Lyon, Université Claude Bernard Lyon 1, CNRS, Institut Lumiére Matiére, Lyon, France
| | - Olivier Tillement
- Univ Lyon, Université Claude Bernard Lyon 1, CNRS, Institut Lumiére Matiére, Lyon, France
| | - Jean-Luc Coll
- Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France
| | - Yannick Crémillieux
- Centre de Résonance Magnétique des Systèmes Biologiques,CNRS UMR 5536, Université Bordeaux, Bordeaux, France
| |
Collapse
|
7
|
Wang L. Screening and Biosensor-Based Approaches for Lung Cancer Detection. SENSORS (BASEL, SWITZERLAND) 2017; 17:E2420. [PMID: 29065541 PMCID: PMC5677261 DOI: 10.3390/s17102420] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/26/2017] [Revised: 10/17/2017] [Accepted: 10/18/2017] [Indexed: 02/07/2023]
Abstract
Early diagnosis of lung cancer helps to reduce the cancer death rate significantly. Over the years, investigators worldwide have extensively investigated many screening modalities for lung cancer detection, including computerized tomography, chest X-ray, positron emission tomography, sputum cytology, magnetic resonance imaging and biopsy. However, these techniques are not suitable for patients with other pathologies. Developing a rapid and sensitive technique for early diagnosis of lung cancer is urgently needed. Biosensor-based techniques have been recently recommended as a rapid and cost-effective tool for early diagnosis of lung tumor markers. This paper reviews the recent development in screening and biosensor-based techniques for early lung cancer detection.
Collapse
Affiliation(s)
- Lulu Wang
- School of Instrument Science and Opto-electronics Engineering, Hefei University of Technology, Hefei 230009, China.
- Institute of Biomedical Technologies, Auckland University of Technology, Auckland 1142, New Zealand.
| |
Collapse
|
8
|
A decade of lung expansion: A review of ventilation-weighted 1 H lung MRI. Z Med Phys 2017; 27:172-179. [DOI: 10.1016/j.zemedi.2016.07.005] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2016] [Revised: 07/10/2016] [Accepted: 07/26/2016] [Indexed: 11/30/2022]
|
9
|
Egger C, Cannet C, Gérard C, Suply T, Ksiazek I, Jarman E, Beckmann N. Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis. Eur J Pharmacol 2017; 809:64-72. [DOI: 10.1016/j.ejphar.2017.05.022] [Citation(s) in RCA: 49] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2016] [Revised: 05/08/2017] [Accepted: 05/10/2017] [Indexed: 11/29/2022]
|
10
|
Müller A, Jagoda P, Fries P, Gräber S, Bals R, Buecker A, Jungnickel C, Beisswenger C. Three-dimensional ultrashort echo time MRI and Short T 2 images generated from subtraction for determination of tumor burden in lung cancer: Preclinical investigation in transgenic mice. Magn Reson Med 2017; 79:1052-1060. [PMID: 28497643 DOI: 10.1002/mrm.26741] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2016] [Revised: 04/09/2017] [Accepted: 04/10/2017] [Indexed: 12/11/2022]
Abstract
PURPOSE To investigate the potential of 3D ultrashort echo time MRI and short T2 images generated by subtraction for determination of total tumor burden in lung cancer. METHODS As an animal model of spontaneously developing non-small cell lung cancer, the K-rasLA1 transgenic mouse was used. Three-dimensional MR imaging was performed with radial k-space acquisition and echo times of 20 µs and 1 ms. For investigation of the short T2 component in the recorded signal, subtraction images were generated from these data sets and used for consensus identification of tumors. Next, manual segmentation was performed on all MR images by two independent investigators. MRI data were compared with the results from histologic investigations and among the investigators. RESULTS Tumor number and total tumor burden from imaging experiments correlated strongly with the results of histologic investigations. Intra- and interuser comparison showed highest correlations between the individual measurements for ultra-short TE MRI. CONCLUSIONS Three-dimensional MRI protocols facilitate accurate tumor identification in mice harboring lung tumors. Ultrashort TE MRI is the superior imaging strategy when investigating lung tumors of miscellaneous size with 3D MR imaging strategies. Magn Reson Med 79:1052-1060, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
Collapse
Affiliation(s)
- Andreas Müller
- Clinic for Diagnostic and Interventional Radiology, Saarland University Hospital, Homburg, Germany
| | - Philippe Jagoda
- Clinic for Diagnostic and Interventional Radiology, Saarland University Hospital, Homburg, Germany
| | - Peter Fries
- Clinic for Diagnostic and Interventional Radiology, Saarland University Hospital, Homburg, Germany
| | - Stefan Gräber
- Department of Internal Medicine V-Pulmonology, Allergology, and Respiratory Critical Care Medicine, Saarland University Hospital, Homburg, Germany
| | - Robert Bals
- Department of Biostatistics and Medical Informatics, Institute for Epidemiology, Saarland University Hospital, Homburg, Germany
| | - Arno Buecker
- Clinic for Diagnostic and Interventional Radiology, Saarland University Hospital, Homburg, Germany
| | - Christopher Jungnickel
- Department of Internal Medicine V-Pulmonology, Allergology, and Respiratory Critical Care Medicine, Saarland University Hospital, Homburg, Germany
| | - Christoph Beisswenger
- Department of Internal Medicine V-Pulmonology, Allergology, and Respiratory Critical Care Medicine, Saarland University Hospital, Homburg, Germany
| |
Collapse
|
11
|
Benson DG, Schiebler ML, Repplinger MD, François CJ, Grist TM, Reeder SB, Nagle SK. Contrast-enhanced pulmonary MRA for the primary diagnosis of pulmonary embolism: current state of the art and future directions. Br J Radiol 2017; 90:20160901. [PMID: 28306332 DOI: 10.1259/bjr.20160901] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
CT pulmonary angiography (CTPA) is currently considered the imaging standard of care for the diagnosis of pulmonary embolism (PE). Recent advances in contrast-enhanced pulmonary MR angiography (MRA) techniques have led to increased use of this modality for the detection of PE in the proper clinical setting. This review is intended to provide an introduction to the state-of-the-art techniques used in pulmonary MRA for the detection of PE and to discuss possible future directions for this modality. This review discusses the following issues pertinent to MRA for the diagnosis of PE: (1) the diagnostic efficacy and clinical effectiveness for pulmonary MRA relative to CTPA, (2) the different pulmonary MRA techniques used for the detection of PE, (3) guidance for building a clinical service at their institution using MRA and (4) future directions of PE MRA. Our principal aim was to show how pulmonary MRA can be used as a safe, effective modality for the diagnosis of clinically significant PE, particularly for those patients where there are concerns about ionizing radiation or contraindications/allergies to the iodinated contrast material.
Collapse
Affiliation(s)
- Donald G Benson
- 1 Department of Radiology, University of Wisconsin-Madison, Madison, WI, USA
| | - Mark L Schiebler
- 1 Department of Radiology, University of Wisconsin-Madison, Madison, WI, USA
| | - Michael D Repplinger
- 1 Department of Radiology, University of Wisconsin-Madison, Madison, WI, USA.,2 Department of Emergency Medicine, University of Wisconsin-Madison, Madison, WI, USA
| | | | - Thomas M Grist
- 1 Department of Radiology, University of Wisconsin-Madison, Madison, WI, USA.,3 Department of Medical Physics, University of Wisconsin-Madison, Madison, WI, USA.,4 Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, USA
| | - Scott B Reeder
- 1 Department of Radiology, University of Wisconsin-Madison, Madison, WI, USA.,2 Department of Emergency Medicine, University of Wisconsin-Madison, Madison, WI, USA.,3 Department of Medical Physics, University of Wisconsin-Madison, Madison, WI, USA.,4 Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, USA.,5 Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA
| | - Scott K Nagle
- 1 Department of Radiology, University of Wisconsin-Madison, Madison, WI, USA.,3 Department of Medical Physics, University of Wisconsin-Madison, Madison, WI, USA.,6 Department of Pediatrics, University of Wisconsin-Madison, Madison, WI, USA
| |
Collapse
|
12
|
Tibiletti M, Bianchi A, Stiller D, Rasche V. Pulmonary perfusion quantification with flow-sensitive inversion recovery (FAIR) UTE MRI in small animal imaging. NMR IN BIOMEDICINE 2016; 29:1791-1799. [PMID: 27809405 DOI: 10.1002/nbm.3657] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/03/2016] [Revised: 09/13/2016] [Accepted: 09/14/2016] [Indexed: 06/06/2023]
Abstract
Blood perfusion in lung parenchyma is an important property for assessing lung function. In small animals, its quantitation is limited even with radioactive isotopes or dynamic contrast-enhanced MRI techniques. In this study, the feasibility flow-sensitive alternating inversion recovery (FAIR) for the quantification of blood flow in lung parenchyma in free breathing rats at 7 T has been investigated. In order to obtain sufficient signal from the short T2 * lung parenchyma, a 2D ultra-short echo time (UTE) Look-Locker read-out has been implemented. Acquisitions were segmented to maintain acquisition time within an acceptable range. A method to perform retrospective respiratory gating (DC-SG) has been applied to investigate the impact of respiratory movement. Reproducibilities within and between sessions were estimated, and the ability of FAIR-UTE to identify the decrease of lung perfusion under hyperoxic conditions was tested. The implemented technique allowed for the visualization of lung parenchyma with excellent SNR and no respiratory artifact even in ungated acquisitions. Lung parenchyma perfusion was obtained as 32.54 ± 2.26 mL/g/min in the left lung, and 34.09 ± 2.75 mL/g/min in the right lung. Application of retrospective gating significantly but minimally changes the perfusion values, implying that respiratory gating may not be necessary with this center-our acquisition method. A decrease of 10% in lung perfusion was found between normoxic and hyperoxic conditions, proving the feasibility of the FAIR-UTE approach to quantify lung perfusion changes.
Collapse
Affiliation(s)
- Marta Tibiletti
- Core Facility Small Animal MRI, 89081 Ulm, University, Albert-Einstein-Allee 23, 89081 Ulm, Germany
| | - Andrea Bianchi
- In-Vivo Imaging Laboratory, Target Discovery Research, Boehringer Ingelheim Pharma, Birkendorfer Strasse 65, 88397 Biberach an der Riss, Germany
| | - Detlef Stiller
- In-Vivo Imaging Laboratory, Target Discovery Research, Boehringer Ingelheim Pharma, Birkendorfer Strasse 65, 88397 Biberach an der Riss, Germany
| | - Volker Rasche
- University Hospital of Ulm, Internal Medicine II, Ulm, Germany
| |
Collapse
|
13
|
Tibiletti M, Bianchi A, Kjørstad Å, Wundrak S, Stiller D, Rasche V. Respiratory self-gated 3DUTE for lung imaging in small animal MRI. Magn Reson Med 2016; 78:739-745. [DOI: 10.1002/mrm.26463] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2016] [Revised: 07/25/2016] [Accepted: 08/23/2016] [Indexed: 01/02/2023]
Affiliation(s)
| | - Andrea Bianchi
- Boehringer Ingelheim Pharma GmbH & Co. KG, Target Discovery Research, In-Vivo Imaging Laboratory; Biberach an der Riss Germany
| | - Åsmund Kjørstad
- Department of Neuroradiology; University Hospital Hamburg-Eppendorf; Hamburg Germany
| | - Stefan Wundrak
- Department of Internal Medicine II; Ulm University; Ulm Germany
| | - Detlef Stiller
- Boehringer Ingelheim Pharma GmbH & Co. KG, Target Discovery Research, In-Vivo Imaging Laboratory; Biberach an der Riss Germany
| | - Volker Rasche
- Core Facility Small Animal MRI; Ulm University; Ulm Germany
- Department of Internal Medicine II; Ulm University; Ulm Germany
| |
Collapse
|
14
|
Tassali N, Bianchi A, Lux F, Raffard G, Sanchez S, Tillement O, Crémillieux Y. MR imaging, targeting and characterization of pulmonary fibrosis using intra-tracheal administration of gadolinium-based nanoparticles. CONTRAST MEDIA & MOLECULAR IMAGING 2016; 11:396-404. [PMID: 27396584 DOI: 10.1002/cmmi.1703] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/10/2015] [Revised: 05/08/2016] [Accepted: 05/27/2016] [Indexed: 01/01/2023]
Abstract
Idiopathic pulmonary fibrosis is a devastating disease. Animal models are critical to develop new diagnostic approaches. We investigate here whether the application of an ultra-short echo time MRI sequence combined with the intra-tracheal administration of Gd-based nanoparticles can help to visualize and characterize pulmonary fibrosis in mice. 21 mice were imaged. Treated mice were administered bleomycin. MRI was used for longitudinal detection of bleomycin-induced lung injury from Day 1 up to Day 60. On Day 30, all mice received nanoparticles and MR images were acquired. A signal enhancement of 120% and 50% in fibrotic lesions and healthy tissues respectively was obtained. A twofold increase of contrast-to-noise ratio between fibrotic and healthy tissue was also observed, leading to a more accurate delineation of the extent of fibrosis. The elimination time constant of the nanoparticles was 54% higher in fibrotic lesions. Bleomycin-induced lung injury can be monitored using MRI. Intra-tracheal administration of Gd-based nanoparticles enabled us to enhance fibrotic tissue in lungs but also to extract imaging biomarkers that quantify elimination and diffusion of contrast agents and can characterize fibrotic tissue. The added value of MRI associated with pulmonary administration of contrast agents is key to better understand the lung fibrotic process and monitor drug response in pre-clinical studies, which will be valuable for translational applications. Copyright © 2016 John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- Nawal Tassali
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université de Bordeaux, Bordeaux, France.
| | - Andrea Bianchi
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université de Bordeaux, Bordeaux, France
| | - François Lux
- Institut Lumière Matière, CNRS UMR 5306, Université Claude Bernard, Villeurbanne, France
| | - Gérard Raffard
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université de Bordeaux, Bordeaux, France
| | - Stéphane Sanchez
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université de Bordeaux, Bordeaux, France
| | - Olivier Tillement
- Institut Lumière Matière, CNRS UMR 5306, Université Claude Bernard, Villeurbanne, France
| | - Yannick Crémillieux
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université de Bordeaux, Bordeaux, France
| |
Collapse
|
15
|
Al Faraj A, Shaik AS, Afzal S, Al-Muhsen S, Halwani R. Specific targeting and noninvasive magnetic resonance imaging of an asthma biomarker in the lung using polyethylene glycol functionalized magnetic nanocarriers. CONTRAST MEDIA & MOLECULAR IMAGING 2015; 11:172-83. [PMID: 26708935 DOI: 10.1002/cmmi.1678] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 06/01/2015] [Revised: 11/09/2015] [Accepted: 11/11/2015] [Indexed: 01/01/2023]
Abstract
Simultaneous inhibition of IL4 and IL13 via the common receptor chain IL4Rα to block adequately their biologic effects presents a promising therapeutic approach to give the additional relief required for asthma patients. In this study, superparamagnetic iron oxide nanoparticles were conjugated with anti-IL4Rα blocking antibodies via polyethylene glycol (PEG) polymers. The delivery of these blocking antibodies to the inflammatory sites in the lung via the developed nanocarriers was assessed using noninvasive free-breathing pulmonary MRI. Biocompatibility assays confirmed the safety of the developed nanocarriers for pre-clinical investigations. For all the investigated formulations, nanocarriers were found to be very stable at neutral pH. However, the stability noticeably decreased with the PEG length in acidic environment and thus the loaded antibodies were preferentially released. Immunofluorescence and fluorimetry assays confirmed the binding of the nanocarriers to the IL4Rα asthma biomarker. Pulmonary MRI performed using an ultra-short echo time sequence allowed simultaneous noninvasive monitoring of inflammatory responses induced by ovalbumin challenge and tracking of the developed nanocarriers, which were found to colocalize with the inflammatory sites in the lung. Targeting of the developed nanocarriers to areas rich in IL4Rα positive inflammatory cells was confirmed using histological and flow cytometry analyses. The anti-IL4Rα-conjugated nanocarriers developed here have been confirmed to be efficient in targeting key inflammatory cells during chronic lung inflammation following intrapulmonary administration. Targeting efficiency was monitored using noninvasive MRI, allowing detection of the nanocarriers' colocalizations with the inflammatory sites in the lung of ovalbumin-challenged asthmatic mice. Copyright © 2015 John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- Achraf Al Faraj
- King Saud University, Department of Radiological Sciences, College of Applied Medical Sciences, Riyadh, Saudi Arabia
| | - Asma Sultana Shaik
- King Saud University, Prince Naif Health Research Center, Riyadh, Saudi Arabia.,King Saud University, Prince Naif Center for Immunology Research and Asthma Research Chair, Department of Pediatrics, College of Medicine, Riyadh, Saudi Arabia
| | - Sibtain Afzal
- King Saud University, Prince Naif Center for Immunology Research and Asthma Research Chair, Department of Pediatrics, College of Medicine, Riyadh, Saudi Arabia
| | - Saleh Al-Muhsen
- King Saud University, Prince Naif Center for Immunology Research and Asthma Research Chair, Department of Pediatrics, College of Medicine, Riyadh, Saudi Arabia
| | - Rabih Halwani
- King Saud University, Prince Naif Center for Immunology Research and Asthma Research Chair, Department of Pediatrics, College of Medicine, Riyadh, Saudi Arabia
| |
Collapse
|
16
|
Marenzana M, Vande Velde G. Refine, reduce, replace: Imaging of fibrosis and arthritis in animal models. Best Pract Res Clin Rheumatol 2015; 29:715-40. [DOI: 10.1016/j.berh.2016.02.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
17
|
Bianchi A, Tibiletti M, Kjørstad Å, Birk G, Schad LR, Stierstorfer B, Rasche V, Stiller D. Three-dimensional accurate detection of lung emphysema in rats using ultra-short and zero echo time MRI. NMR IN BIOMEDICINE 2015; 28:1471-1479. [PMID: 26403226 DOI: 10.1002/nbm.3417] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/06/2015] [Revised: 08/10/2015] [Accepted: 08/26/2015] [Indexed: 06/05/2023]
Abstract
Emphysema is a life-threatening pathology that causes irreversible destruction of alveolar walls. In vivo imaging techniques play a fundamental role in the early non-invasive pre-clinical and clinical detection and longitudinal follow-up of this pathology. In the present study, we aimed to evaluate the feasibility of using high resolution radial three-dimensional (3D) zero echo time (ZTE) and 3D ultra-short echo time (UTE) MRI to accurately detect lung pathomorphological changes in a rodent model of emphysema.Porcine pancreas elastase (PPE) was intratracheally administered to the rats to produce the emphysematous changes. 3D ZTE MRI, low and high definition 3D UTE MRI and micro-computed tomography images were acquired 4 weeks after the PPE challenge. Signal-to-noise ratios (SNRs) were measured in PPE-treated and control rats. T2* values were computed from low definition 3D UTE MRI. Histomorphometric measurements were made after euthanizing the animals. Both ZTE and UTE MR images showed a significant decrease in the SNR measured in PPE-treated lungs compared with controls, due to the pathomorphological changes taking place in the challenged lungs. A significant decrease in T2* values in PPE-challenged animals compared with controls was measured using UTE MRI. Histomorphometric measurements showed a significant increase in the mean linear intercept in PPE-treated lungs. UTE yielded significantly higher SNR compared with ZTE (14% and 30% higher in PPE-treated and non-PPE-treated lungs, respectively).This study showed that optimized 3D radial UTE and ZTE MRI can provide lung images of excellent quality, with high isotropic spatial resolution (400 µm) and SNR in parenchymal tissue (>25) and negligible motion artifacts in freely breathing animals. These techniques were shown to be useful non-invasive instruments to accurately and reliably detect the pathomorphological alterations taking place in emphysematous lungs, without incurring the risks of cumulative radiation exposure typical of micro-computed tomography.
Collapse
Affiliation(s)
- Andrea Bianchi
- Boehringer Ingelheim Pharma GmbH & Co. KG, Target Discovery Research, In-Vivo Imaging Laboratory, Biberach an der Riss, Germany
| | - Marta Tibiletti
- Core Facility Small Animal MRI, Ulm University, Ulm, Germany
| | - Åsmund Kjørstad
- Computer Assisted Clinical Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
- Department of Neuroradiology, University Hospital Hamburg-Eppendorf, Germany
| | - Gerald Birk
- Boehringer Ingelheim Pharma GmbH & Co. KG, Target Discovery Research, Target Validation Technologies, Biberach an der Riss, Germany
| | - Lothar R Schad
- Computer Assisted Clinical Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Birgit Stierstorfer
- Boehringer Ingelheim Pharma GmbH & Co. KG, Target Discovery Research, Target Validation Technologies, Biberach an der Riss, Germany
| | - Volker Rasche
- Core Facility Small Animal MRI, Ulm University, Ulm, Germany
- Department of Internal Medicine II, Ulm University, Ulm, Germany
| | - Detlef Stiller
- Boehringer Ingelheim Pharma GmbH & Co. KG, Target Discovery Research, In-Vivo Imaging Laboratory, Biberach an der Riss, Germany
| |
Collapse
|
18
|
Bannas P, Bell LC, Johnson KM, Schiebler ML, François CJ, Motosugi U, Consigny D, Reeder SB, Nagle SK. Pulmonary Embolism Detection with Three-dimensional Ultrashort Echo Time MR Imaging: Experimental Study in Canines. Radiology 2015; 278:413-21. [PMID: 26422185 DOI: 10.1148/radiol.2015150606] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
PURPOSE To demonstrate the feasibility of free-breathing three-dimensional (3D) radial ultrashort echo time (UTE) magnetic resonance (MR) imaging in the simultaneous detection of pulmonary embolism (PE) and high-quality evaluation of lung parenchyma. MATERIALS AND METHODS The institutional animal care committee approved this study. A total of 12 beagles underwent MR imaging and computed tomography (CT) before and after induction of PE with autologous clots. Breath-hold 3D MR angiography and free-breathing 3D radial UTE (1.0-mm isotropic spatial resolution; echo time, 0.08 msec) were performed at 3 T. Two blinded radiologists independently marked and graded all PEs on a four-point scale (1 = low confidence, 4 = absolutely certain) on MR angiographic and UTE images. Image quality of pulmonary arteries and lung parenchyma was scored on a four-point-scale (1 = poor, 4 = excellent). Locations and ratings of emboli were compared with reference standard CT images by using an alternative free-response receiver operating characteristic curve (AFROC) method. Areas under the curve and image quality ratings were compared by using the F test and the Wilcoxon signed-rank test. RESULTS A total of 48 emboli were detected with CT. Both readers showed higher sensitivity for PE detection with UTE (83% and 79%) than with MR angiography (75% and 71%). The AFROC area under the curve was higher for UTE than for MR angiography (0.95 vs 0.89), with a significant difference in area under the curve of 0.06 (95% confidence interval: 0.01, 0.11; P = .018). UTE image quality exceeded that of MR angiography for subsegmental arteries (3.5 ± 0.7 vs 2.9 ± 0.5, P = .002) and lung parenchyma (3.8 ± 0.5 vs 2.2 ± 0.2, P < .001). The apparent signal-to-noise ratio in pulmonary arteries and lung parenchyma was significantly higher for UTE than for MR angiography (41.0 ± 5.2 vs 24.5 ± 6.2 [P < .001] and 10.2 ± 1.8 vs 3.5 ± 0.8 [P < .001], respectively). The apparent contrast-to-noise ratio between arteries and PEs was higher for UTE than for MR angiography (20.3 ± 5.2 vs 15.4 ± 6.7, P = .055). CONCLUSION In a canine model, free-breathing 3D radial UTE performs better than breath-hold 3D MR angiography in the detection of PE and yields better image quality for visualization of small vessels and lung parenchyma. Free-breathing 3D radial UTE for detection of PE is feasible and warrants evaluation in human subjects.
Collapse
Affiliation(s)
- Peter Bannas
- From the Departments of Radiology (P.B., M.L.S., C.J.F., U.M., D.C., S.B.R., S.K.N.), Medical Physics (L.C.B., K.M.J., S.B.R., S.K.N.), Biomedical Engineering (S.B.R.), Medicine (S.B.R.), Emergency Medicine (S.B.R.), and Pediatrics (S.K.N.), University of Wisconsin-Madison, 600 Highland Ave, Madison, WI 53792-3252
| | - Laura C Bell
- From the Departments of Radiology (P.B., M.L.S., C.J.F., U.M., D.C., S.B.R., S.K.N.), Medical Physics (L.C.B., K.M.J., S.B.R., S.K.N.), Biomedical Engineering (S.B.R.), Medicine (S.B.R.), Emergency Medicine (S.B.R.), and Pediatrics (S.K.N.), University of Wisconsin-Madison, 600 Highland Ave, Madison, WI 53792-3252
| | - Kevin M Johnson
- From the Departments of Radiology (P.B., M.L.S., C.J.F., U.M., D.C., S.B.R., S.K.N.), Medical Physics (L.C.B., K.M.J., S.B.R., S.K.N.), Biomedical Engineering (S.B.R.), Medicine (S.B.R.), Emergency Medicine (S.B.R.), and Pediatrics (S.K.N.), University of Wisconsin-Madison, 600 Highland Ave, Madison, WI 53792-3252
| | - Mark L Schiebler
- From the Departments of Radiology (P.B., M.L.S., C.J.F., U.M., D.C., S.B.R., S.K.N.), Medical Physics (L.C.B., K.M.J., S.B.R., S.K.N.), Biomedical Engineering (S.B.R.), Medicine (S.B.R.), Emergency Medicine (S.B.R.), and Pediatrics (S.K.N.), University of Wisconsin-Madison, 600 Highland Ave, Madison, WI 53792-3252
| | - Christopher J François
- From the Departments of Radiology (P.B., M.L.S., C.J.F., U.M., D.C., S.B.R., S.K.N.), Medical Physics (L.C.B., K.M.J., S.B.R., S.K.N.), Biomedical Engineering (S.B.R.), Medicine (S.B.R.), Emergency Medicine (S.B.R.), and Pediatrics (S.K.N.), University of Wisconsin-Madison, 600 Highland Ave, Madison, WI 53792-3252
| | - Utaroh Motosugi
- From the Departments of Radiology (P.B., M.L.S., C.J.F., U.M., D.C., S.B.R., S.K.N.), Medical Physics (L.C.B., K.M.J., S.B.R., S.K.N.), Biomedical Engineering (S.B.R.), Medicine (S.B.R.), Emergency Medicine (S.B.R.), and Pediatrics (S.K.N.), University of Wisconsin-Madison, 600 Highland Ave, Madison, WI 53792-3252
| | - Daniel Consigny
- From the Departments of Radiology (P.B., M.L.S., C.J.F., U.M., D.C., S.B.R., S.K.N.), Medical Physics (L.C.B., K.M.J., S.B.R., S.K.N.), Biomedical Engineering (S.B.R.), Medicine (S.B.R.), Emergency Medicine (S.B.R.), and Pediatrics (S.K.N.), University of Wisconsin-Madison, 600 Highland Ave, Madison, WI 53792-3252
| | - Scott B Reeder
- From the Departments of Radiology (P.B., M.L.S., C.J.F., U.M., D.C., S.B.R., S.K.N.), Medical Physics (L.C.B., K.M.J., S.B.R., S.K.N.), Biomedical Engineering (S.B.R.), Medicine (S.B.R.), Emergency Medicine (S.B.R.), and Pediatrics (S.K.N.), University of Wisconsin-Madison, 600 Highland Ave, Madison, WI 53792-3252
| | - Scott K Nagle
- From the Departments of Radiology (P.B., M.L.S., C.J.F., U.M., D.C., S.B.R., S.K.N.), Medical Physics (L.C.B., K.M.J., S.B.R., S.K.N.), Biomedical Engineering (S.B.R.), Medicine (S.B.R.), Emergency Medicine (S.B.R.), and Pediatrics (S.K.N.), University of Wisconsin-Madison, 600 Highland Ave, Madison, WI 53792-3252
| |
Collapse
|
19
|
Tibiletti M, Kjørstad Å, Bianchi A, Schad LR, Stiller D, Rasche V. Multistage self-gated lung imaging in small rodents. Magn Reson Med 2015; 75:2448-54. [DOI: 10.1002/mrm.25849] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2015] [Revised: 05/28/2015] [Accepted: 06/26/2015] [Indexed: 12/30/2022]
Affiliation(s)
| | - Åsmund Kjørstad
- Computer Assisted Clinical Medicine, Medical Faculty Mannheim; Heidelberg University; Mannheim Germany
- Department of Neuroradiology; University Hospital Hamburg-Eppendorf; Germany
| | - Andrea Bianchi
- Target Discovery Research, In-vivo imaging laboratory; Boehringer Ingelheim Pharma GmbH & Co. KG; Biberach an der Riss Germany
| | - Lothar R. Schad
- Computer Assisted Clinical Medicine, Medical Faculty Mannheim; Heidelberg University; Mannheim Germany
| | - Detlef Stiller
- Target Discovery Research, In-vivo imaging laboratory; Boehringer Ingelheim Pharma GmbH & Co. KG; Biberach an der Riss Germany
| | - Volker Rasche
- Core Facility Small Animal MRI; Ulm University; Ulm Germany
- Internal Medicine II; University Hospital Ulm; Ulm Germany
| |
Collapse
|
20
|
Magnetic resonance imaging for noninvasive assessment of lung fibrosis onset and progression: cross-validation and comparison of different magnetic resonance imaging protocols with micro-computed tomography and histology in the bleomycin-induced mouse model. Invest Radiol 2015; 49:691-8. [PMID: 24872004 DOI: 10.1097/rli.0000000000000071] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
OBJECTIVES Bleomycin instillation is frequently used to model lung fibrosis, although the onset and severity of pathology varies highly between mice. This makes non-invasive fibrosis detection and quantification essential to obtain a comprehensive analysis of the disease course and to validate novel therapies. Magnetic resonance imaging (MRI) of lung disease progression and therapy may provide such a sensitive in vivo readout of lung fibrosis, bypassing radiotoxicity concerns (when using micro-CT [μCT]) and elaborate invasive end point measurements (histology). We aimed to optimize and evaluate 3 different lung MRI contrast and acquisition methods to visualize disease onset and progression in the bleomycin-induced mouse model of lung fibrosis using a small-animal MRI scanner. For validation, we compared the MRI results with established μCT and histological measures of lung fibrosis. MATERIALS AND METHODS Free-breathing bleomycin-instilled and control mice were scanned in vivo with respiration-triggered conventional, ultrashort echo time and self-gated MRI pulse sequences (9.4 T) and μCT at baseline and weekly at days 7, 14, 21, and 28 after bleomycin instillation. After the last imaging time point, the mice were killed and the lungs were isolated for criterion standard histological analysis of lung fibrosis and quantification of lung collagen content for validation of the imaging results. The agreement between quantitative MRI and μCT data and standard measurements was analyzed by linear regression. RESULTS All 3 MRI protocols were able to visualize and quantify lung pathology onset and progression in individual bleomycin-instilled mice. In vivo MRI results were in excellent agreement with in vivo μCT and criterion standard histological measures of lung fibrosis. Ultrashort echo time MRI appeared particularly useful for detecting early disease; self-gated MRI, for improved breathing motion handling. DISCUSSION Magnetic resonance imaging sensitively visualizes and quantifies lung fibrosis in vivo, which makes it a noninvasive, translatable, safe, and potentially more versatile alternative to invasive methods or μCT, thereby stimulating pathogenesis and preclinical research.
Collapse
|
21
|
Bianchi A, Moncelet D, Lux F, Plissonneau M, Rizzitelli S, Ribot EJ, Tassali N, Bouchaud V, Tillement O, Voisin P, Crémillieux Y. Orotracheal administration of contrast agents: a new protocol for brain tumor targeting. NMR IN BIOMEDICINE 2015; 28:738-746. [PMID: 25921808 DOI: 10.1002/nbm.3295] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/13/2014] [Revised: 02/17/2015] [Accepted: 03/07/2015] [Indexed: 06/04/2023]
Abstract
The development of new non-invasive diagnostic and therapeutic approaches is of paramount importance in order to improve the outcome of patients with glioblastoma (GBM). In this work we investigated a completely non-invasive pre-clinical protocol to effectively target and detect brain tumors through the orotracheal route, using ultra-small nanoparticles (USRPs) and MRI. A mouse model of GBM was developed. In vivo MRI acquisitions were performed before and after intravenous or orotracheal administration of the nanoparticles to identify and segment the tumor. The accumulation of the nanoparticles in neoplastic lesions was assessed ex vivo through fluorescence microscopy. Before the administration of contrast agents, MR images allowed the identification of the presence of abnormal brain tissue in 73% of animals. After orotracheal or intravenous administration of USRPs, in all the mice an excellent co-localization of the position of the tumor with MRI and histology was observed. The elimination time of the USRPs from the tumor after the orotracheal administration was approximately 70% longer compared with intravenous injection. MRI and USRPs were shown to be powerful imaging tools able to detect, quantify and longitudinally monitor the development of GBMs. The absence of ionizing radiation and high resolution of MRI, along with the complete non-invasiveness and good reproducibility of the proposed protocol, make this technique potentially translatable to humans. To our knowledge, this is the first time that the advantages of a needle-free orotracheal administration route have been demonstrated for the investigation of the pathomorphological changes due to GBMs.
Collapse
Affiliation(s)
- Andrea Bianchi
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | - Damien Moncelet
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | - François Lux
- Institut Lumière Matière, CNRS UMR 5306, Université Claude Bernard, Domaine Scientifique de La Doua, Villeurbanne, France
| | - Marie Plissonneau
- Institut Lumière Matière, CNRS UMR 5306, Université Claude Bernard, Domaine Scientifique de La Doua, Villeurbanne, France
- Nano-H SAS, Saint-Quentin Fallavier, France
| | - Silvia Rizzitelli
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | - Emeline Julie Ribot
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | - Nawal Tassali
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | - Véronique Bouchaud
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | - Olivier Tillement
- Institut Lumière Matière, CNRS UMR 5306, Université Claude Bernard, Domaine Scientifique de La Doua, Villeurbanne, France
| | - Pierre Voisin
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | - Yannick Crémillieux
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| |
Collapse
|
22
|
|
23
|
Molinari F, Madhuranthakam AJ, Lenkinski R, Bankier AA. Ultrashort echo time MRI of pulmonary water content: assessment in a sponge phantom at 1.5 and 3.0 Tesla. Diagn Interv Radiol 2015; 20:34-41. [PMID: 24317335 DOI: 10.5152/dir.2013.13232] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
PURPOSE We aimed to develop a predictive model for lung water content using ultrashort echo time (UTE) magnetic resonance imaging (MRI) and a sponge phantom. MATERIALS AND METHODS Image quality was preliminarily optimized, and the signal-to-noise ratio (SNR) of UTE was compared with that obtained from a three-dimensional fast gradient echo (FGRE) sequence. Four predetermined volumes of water (3.5, 3.0, 2.5, and 2.0 mL) were soaked in cellulose foam sponges 1.8 cm3 in size and were imaged with UTE-MRI at 1.5 and 3.0 Tesla (T). A multiple echo time experiment (range, 0.1-9.6 ms) was conducted, and the T2 signal decay curve was determined at each volume of water. A three-parameter equation was fitted to the measured signal, allowing for the calculation of proton density and T2*. The calculation error of proton density was determined as a function of echo time. The constants that allowed for the determination of unknown volumes of water from the measured proton density were calculated using linear regression. RESULTS UTE-MRI provided excellent image quality for the four phantoms and showed a higher SNR, compared to that of FGRE. Proton density decreased proportionally with the decreases in both lung water and field strength (from 3.5 to 2.0 mL; proton density range at 1.5 T, 30.5-17.3; at 3.0 T, 84.2-41.5). Minimum echo time less than 0.6 ms at 1.5 T and 1 ms at 3.0 T maintained calculation errors for proton density within the range of 0%-10%. The slopes of the lines for determining the unknown volumes of water with UTE-MRI were 0.12±0.003 at 1.5 T and 0.05±0.002 at 3.0 T (P < 0.0001). CONCLUSION In a sponge phantom imaged at 1.5 and 3.0 T, unknown volumes of water can be predicted with high accuracy using UTE-MRI.
Collapse
Affiliation(s)
- Francesco Molinari
- From the Department of Radiology (F.M. e-mail: , R.L., A.A.B.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA; Global Applied Science Laboratory (A.J.M.), GE Healthcare, Boston, Massachusetts, USA
| | | | | | | |
Collapse
|
24
|
Nofiele JT, Cheng W, Haedicke IE, Ganesh T, Zhang XA, Cheng HLM. Ultrashort Echo Time Magnetic Resonance Imaging of the Lung Using a High-Relaxivity T1Blood-Pool Contrast Agent. Mol Imaging 2014; 13. [DOI: 10.2310/7290.2014.00027] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Affiliation(s)
- Joris Tchouala Nofiele
- From The Institute of Biomaterials & Biomedical Engineering, The Edward S. Rogers Sr. Department of Electrical & Computer Engineering, Departments of Medical Biophysics and Chemistry, Leslie Dan Faculty of Pharmacy, University of Toronto; Departments of Physical and Environmental Sciences and Biological Sciences, University of Toronto Scarborough; and SickKids Research Institute, The Hospital for Sick Children, Toronto, ON
| | - Weiran Cheng
- From The Institute of Biomaterials & Biomedical Engineering, The Edward S. Rogers Sr. Department of Electrical & Computer Engineering, Departments of Medical Biophysics and Chemistry, Leslie Dan Faculty of Pharmacy, University of Toronto; Departments of Physical and Environmental Sciences and Biological Sciences, University of Toronto Scarborough; and SickKids Research Institute, The Hospital for Sick Children, Toronto, ON
| | - Inga E. Haedicke
- From The Institute of Biomaterials & Biomedical Engineering, The Edward S. Rogers Sr. Department of Electrical & Computer Engineering, Departments of Medical Biophysics and Chemistry, Leslie Dan Faculty of Pharmacy, University of Toronto; Departments of Physical and Environmental Sciences and Biological Sciences, University of Toronto Scarborough; and SickKids Research Institute, The Hospital for Sick Children, Toronto, ON
| | - Tameshwar Ganesh
- From The Institute of Biomaterials & Biomedical Engineering, The Edward S. Rogers Sr. Department of Electrical & Computer Engineering, Departments of Medical Biophysics and Chemistry, Leslie Dan Faculty of Pharmacy, University of Toronto; Departments of Physical and Environmental Sciences and Biological Sciences, University of Toronto Scarborough; and SickKids Research Institute, The Hospital for Sick Children, Toronto, ON
| | - Xiao-an Zhang
- From The Institute of Biomaterials & Biomedical Engineering, The Edward S. Rogers Sr. Department of Electrical & Computer Engineering, Departments of Medical Biophysics and Chemistry, Leslie Dan Faculty of Pharmacy, University of Toronto; Departments of Physical and Environmental Sciences and Biological Sciences, University of Toronto Scarborough; and SickKids Research Institute, The Hospital for Sick Children, Toronto, ON
| | - Hai-Ling Margaret Cheng
- From The Institute of Biomaterials & Biomedical Engineering, The Edward S. Rogers Sr. Department of Electrical & Computer Engineering, Departments of Medical Biophysics and Chemistry, Leslie Dan Faculty of Pharmacy, University of Toronto; Departments of Physical and Environmental Sciences and Biological Sciences, University of Toronto Scarborough; and SickKids Research Institute, The Hospital for Sick Children, Toronto, ON
| |
Collapse
|
25
|
Weiger M, Wu M, Wurnig MC, Kenkel D, Jungraithmayr W, Boss A, Pruessmann KP. Rapid and robust pulmonary proton ZTE imaging in the mouse. NMR IN BIOMEDICINE 2014; 27:1129-1134. [PMID: 25066371 DOI: 10.1002/nbm.3161] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/26/2014] [Revised: 06/17/2014] [Accepted: 06/17/2014] [Indexed: 06/03/2023]
Abstract
Pulmonary MRI is challenging because of the low proton density and rapid transverse relaxation in the lung associated with microscopic magnetic field inhomogeneities caused by tissue-air interfaces. Therefore, low signal is obtained in gradient and spin echo proton images. Alternatively, non-proton MRI using hyperpolarized gases or radial techniques with ultrashort or zero TE have been proposed to image the lung. Also with the latter approach, the general challenge remains to provide full coverage of the lung at sufficient spatial resolution, signal-to-noise ratio (SNR) and image quality within a reasonable scan time. This task is further aggravated by physiological motion and is particularly demanding in small animals, such as mice. In this work, three-dimensional (3D) zero echo time (ZTE) imaging is employed for efficient pulmonary MRI. Four protocols with different averaging and respiratory triggering schemes are developed and compared with respect to image quality and SNR. To address the critical issue of background signal in ZTE images, a subtraction approach is proposed, providing images virtually free of disturbing signal from nearby hardware parts. The protocols are tested for pulmonary MRI in six mice at 4.7 T, consistently providing images of high quality with a 3D isotropic resolution of 313 µm and SNR values in the lung between 8.0 and 18.5 within scan times between 1 min 21 s and 4 min 44 s. A generally high robustness of the ZTE approach against motion is observed, whilst respiratory triggering further improves the SNR and visibility of image details. The developed techniques are expected to enable efficient preclinical animal studies in the lung and will also be of importance for human applications. Further improvements are expected from radiofrequency (RF) coils with increased SNR and reduced background signal.
Collapse
Affiliation(s)
- Markus Weiger
- Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland
| | | | | | | | | | | | | |
Collapse
|
26
|
Bianchi A, Dufort S, Fortin PY, Lux F, Raffard G, Tassali N, Tillement O, Coll JL, Crémillieux Y. In vivo MRI for effective non-invasive detection and follow-up of an orthotopic mouse model of lung cancer. NMR IN BIOMEDICINE 2014; 27:971-979. [PMID: 24913958 DOI: 10.1002/nbm.3142] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/05/2014] [Revised: 04/24/2014] [Accepted: 04/25/2014] [Indexed: 06/03/2023]
Abstract
One of the main reasons for the dismal prognosis of lung cancer is related to the late diagnosis of this pathology. In this study, we evaluated the potential of optimized lung MRI techniques as a completely non-invasive approach for non-small-cell lung cancer (NSCLC) MRI in vivo detection and follow-up in a mouse model of lung adenocarcinoma expressing the luciferase gene. Bioluminescent lung tumour cells were orthotopically implanted in immuno-deficient mice. Ultra-short echo-time (UTE) MRI free-breathing acquisitions were compared with standard gradient-echo lung MRI (FLASH) using both respiratory-gated and free-breathing protocols. The MRI findings were validated against bioluminescence imaging (BLI) and gold-standard histopathology analysis. Adenocarcinoma-like pathological tissue was successfully identified in all the mice with gated-FLASH and non-gated UTE MRI, and good tumour co-localization was found between MRI, BLI and histological analyses. An excellent or good correlation was found between the measured bioluminescent signal and the total tumour volumes quantified with UTE MRI or gated-FLASH MRI, respectively. No significant correlation was found when the tumours were segmented on non-gated MR FLASH images. MRI was shown to be a powerful imaging tool able to detect, quantify and longitudinally monitor the development of sub-millimetric NSCLCs. To our knowledge, this is the first study which proves the feasibility of a completely non-invasive MRI quantitative detection of lung adenocarcinoma in freely breathing mice. The absence of ionizing radiation and the high-resolution of MRI, along with the complete non-invasiveness and good reproducibility of the proposed non-gated protocol, make this imaging tool ideal for direct translational applications.
Collapse
Affiliation(s)
- Andrea Bianchi
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR 5536, Université Bordeaux Segalen, 146, rue Léo Saignat, Bordeaux, France
| | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Kobayashi N, Idiyatullin D, Corum C, Weber J, Garwood M, Sachdev D. SWIFT MRI enhances detection of breast cancer metastasis to the lung. Magn Reson Med 2014; 73:1812-9. [PMID: 24919566 DOI: 10.1002/mrm.25301] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2013] [Revised: 04/11/2014] [Accepted: 05/02/2014] [Indexed: 01/19/2023]
Abstract
PURPOSE To evaluate the capability of longitudinal MR scans using sweep imaging with Fourier transformation (SWIFT) to detect breast cancer metastasis to the lung in mice. METHODS Mice with breast cancer metastatic to the lung were generated by tail vein injection of MDA-MB-231-LM2 cells. Thereafter, MR imaging was performed every week using three different pulse sequences: SWIFT [echo time (TE) ∼3 μs], concurrent dephasing and excitation (CODE; TE ∼300 μs), and three-dimensional (3D) gradient echo (GRE; TE = 2.2 ms). Motion during the long SWIFT MR scans was compensated for by rigid-body motion correction. Maximum intensity projection (MIP) images were generated to visualize changes in lung vascular structures during the development and growth of metastases. RESULTS SWIFT MRI was more sensitive to signals from the lung parenchyma than CODE or 3D GRE MRI. Metastatic tumor growth in the lungs induced a progressive increase in intensity of parenchymal signals in SWIFT images. MIP images from SWIFT clearly visualized lung vascular structures and their disruption due to progression of breast cancer metastases in the lung. CONCLUSION SWIFT MRI's sensitivity to fast-decaying signals and tolerance of magnetic susceptibility enhances its effectiveness at detecting structural changes in lung parenchyma and vasculature due to breast cancer metastases in the lung.
Collapse
Affiliation(s)
- Naoharu Kobayashi
- Center for Magnetic Resonance Research and Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA
| | | | | | | | | | | |
Collapse
|
28
|
Targeting and in vivo imaging of non-small-cell lung cancer using nebulized multimodal contrast agents. Proc Natl Acad Sci U S A 2014; 111:9247-52. [PMID: 24927562 DOI: 10.1073/pnas.1402196111] [Citation(s) in RCA: 46] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
One of the main reasons for the dismal prognosis of lung cancer is related to the late diagnosis of this pathology. In this work, we evaluated the potential of optimized lung MRI techniques and nebulized ultrasmall multimodal gadolinium-based contrast agents [ultrasmall rigid platforms (USRPs)] as a completely noninvasive approach for non-small-cell lung cancer (NSCLC) in vivo detection. A mouse model of NSCLC expressing the luciferase gene was developed. Ultrashort echo-time free-breathing MRI acquisitions were performed before and after i.v. or intrapulmonary administration of the nanoparticles to identify and segment the tumor. After orotracheal or i.v. administration of USRPs, an excellent colocalization of the position the tumor with MRI, bioluminescence and fluorescence reflectance imaging, and histology was observed in all mice. Significantly higher signal enhancements and contrast-to-noise ratios were observed with orotracheal administration using lower doses, reducing the toxicity issues and the interobserver variability in tumor detection. The observations suggested the existence of an unknown original mechanism (different from the enhanced permeability and retention effect) responsible for this phenomenon. MRI and USRPs were shown to be powerful imaging tools able to detect, quantify, and longitudinally monitor the development of submillimetric NSCLCs. The absence of ionizing radiation and high resolution MRI, along with the complete noninvasiveness and good reproducibility of the proposed protocol, make this technique potentially translatable to humans. To our knowledge this is the first time that the advantages of an orotracheal administration route are demonstrated for the investigation of the pathomorphological changes due to NSCLCs.
Collapse
|
29
|
Egger C, Gérard C, Vidotto N, Accart N, Cannet C, Dunbar A, Tigani B, Piaia A, Jarai G, Jarman E, Schmid HA, Beckmann N. Lung volume quantified by MRI reflects extracellular-matrix deposition and altered pulmonary function in bleomycin models of fibrosis: effects of SOM230. Am J Physiol Lung Cell Mol Physiol 2014; 306:L1064-77. [PMID: 24727584 DOI: 10.1152/ajplung.00027.2014] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
Idiopathic pulmonary fibrosis is a progressive and lethal disease, characterized by loss of lung elasticity and alveolar surface area, secondary to alveolar epithelial cell injury, reactive inflammation, proliferation of fibroblasts, and deposition of extracellular matrix. The effects of oropharyngeal aspiration of bleomycin in Sprague-Dawley rats and C57BL/6 mice, as well as of intratracheal administration of ovalbumin to actively sensitized Brown Norway rats on total lung volume as assessed noninvasively by magnetic resonance imaging (MRI) were investigated here. Lung injury and volume were quantified by using nongated or respiratory-gated MRI acquisitions [ultrashort echo time (UTE) or gradient-echo techniques]. Lung function of bleomycin-challenged rats was examined additionally using a flexiVent system. Postmortem analyses included histology of collagen and hydroxyproline assays. Bleomycin induced an increase of MRI-assessed total lung volume, lung dry and wet weights, and hydroxyproline content as well as collagen amount. In bleomycin-treated rats, gated MRI showed an increased volume of the lung in the inspiratory and expiratory phases of the respiratory cycle and a temporary decrease of tidal volume. Decreased dynamic lung compliance was found in bleomycin-challenged rats. Bleomycin-induced increase of MRI-detected lung volume was consistent with tissue deposition during fibrotic processes resulting in decreased lung elasticity, whereas influences by edema or emphysema could be excluded. In ovalbumin-challenged rats, total lung volume quantified by MRI remained unchanged. The somatostatin analog, SOM230, was shown to have therapeutic effects on established bleomycin-induced fibrosis in rats. This work suggests MRI-detected total lung volume as readout for tissue-deposition in small rodent bleomycin models of pulmonary fibrosis.
Collapse
Affiliation(s)
- Christine Egger
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland; University of Basel, Biocenter, Basel, Switzerland
| | - Christelle Gérard
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland
| | - Nella Vidotto
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland
| | - Nathalie Accart
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland
| | - Catherine Cannet
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland
| | - Andrew Dunbar
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland
| | - Bruno Tigani
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland
| | - Alessandro Piaia
- Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland
| | - Gabor Jarai
- Novartis Institutes for BioMedical Research, Respiratory Diseases Department, Horsham, United Kingdom; and
| | - Elizabeth Jarman
- Novartis Institutes for BioMedical Research, Respiratory Diseases Department, Horsham, United Kingdom; and
| | - Herbert A Schmid
- Novartis Institutes for BioMedical Research, Oncology Department, Basel, Switzerland
| | - Nicolau Beckmann
- Novartis Institutes for BioMedical Research, Analytical Sciences and Imaging, Basel, Switzerland;
| |
Collapse
|
30
|
Bell LC, Johnson KM, Fain SB, Wentland A, Drees R, Johnson RA, Bauman G, Francois CJ, Nagle SK. Simultaneous MRI of lung structure and perfusion in a single breathhold. J Magn Reson Imaging 2013; 41:52-9. [PMID: 24357054 DOI: 10.1002/jmri.24520] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2013] [Accepted: 10/31/2013] [Indexed: 11/10/2022] Open
Abstract
PURPOSE To develop and demonstrate a breathheld 3D radial ultrashort echo time (UTE) acquisition to visualize co-registered lung perfusion and vascular structure. MATERIALS AND METHODS Nine healthy dogs were scanned twice at 3 Tesla (T). Contrast-enhanced pulmonary perfusion scans were acquired with a temporally interleaved three-dimensional (3D) radial UTE (TE = 0.08 ms) sequence in a breathhold (1 s time frames over a 33 s breathhold). The 3D breathheld volume was reconstructed into time-resolved perfusion datasets, and a composite vascular structure dataset. For structural comparison, a 5 min respiratory-gated 3D radial UTE scan was acquired. Data were analyzed by quantitative metrics and radiologist scoring. RESULTS Appropriate time-course of contrast was seen in all subjects. Right ventricle to aorta transit times were 7.4 ± 2.0 s. Relative lung enhancement was a factor of 8.4 ± 1.5. Radiologist scoring showed similarly excellent visualization of the pulmonary arteries to the subsegmental level in breathheld (94% of cases) and respiratory-gated (100% of cases) acquisitions (P = 0.33) despite the aggressive under sampling in the breathheld scan. Similarly, differentiation of lung tissue and airways was achieved by both acquisition methods. CONCLUSION A time-resolved 3D radial UTE sequence for simultaneous imaging of pulmonary perfusion and co-registered vascular structure is feasible.
Collapse
Affiliation(s)
- Laura C Bell
- School of Medicine and Public Health, Department of Medical Physics, Wisconsin, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Bianchi A, Ozier A, Ousova O, Raffard G, Crémillieux Y. Ultrashort-TE MRI longitudinal study and characterization of a chronic model of asthma in mice: inflammation and bronchial remodeling assessment. NMR IN BIOMEDICINE 2013; 26:1451-1459. [PMID: 23761222 DOI: 10.1002/nbm.2975] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/02/2012] [Revised: 04/15/2013] [Accepted: 04/16/2013] [Indexed: 06/02/2023]
Abstract
Asthma is a chronic disease characterized by bronchial hyperresponsiveness (BHR), bronchial inflammation and remodeling. The great improvements in (1)H MRI ultrashort-TE (UTE) sequences in the last decade have allowed lung images with high-resolution and good signal-to-noise ratio to be obtained in parenchymal tissues. In this article, we present a UTE (1)H MRI high-resolution study of a chronic model of asthma in mice with the aim to longitudinally assess the main features of asthma using a fully noninvasive approach. Balb/c mice (n = 6) were sensitized with ovalbumin over a period of 75 days. The control group (n = 3) received normal saline on the same days. MRI acquisitions were performed on days 0, 38 and 78 to study the inflammatory volumes and bronchial remodeling (peribronchial signal intensity index, PBSI). Plethysmographic studies were performed on days 0, 39 and 79 to assess BHR to methacholine using the enhanced pause (Penh) ratio. The average inflammatory volume measured by MRI in the ovalbumin group (15.6 ± 2.4 μL) was increased significantly relative to control mice (-0.3 ± 0.7 μL) on day 38. The inflammatory volume was larger (34.2 ± 3.1 μL) on day 78 in the ovalbumin group. PBSI was significantly higher in the ovalbumin group on day 78 (1.53 ± 0.08) relative to the control group (1.16 ± 0.10), but not on day 38. After sensitization, asthmatic mice presented BHR to methacholine on days 39 and 79. Penh ratios correlated significantly with the inflammatory volume on day 39 and with the PBSI on day 79. This study shows, for the first time, that high-resolution UTE (1)H MRI of the lungs may allow the noninvasive quantification of peribronchial eosinophilic inflammation with airways occlusion by mucus and of bronchial remodeling in a murine asthma model that correlates with functional parameters.
Collapse
Affiliation(s)
- Andrea Bianchi
- Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, Université Bordeaux Segalen, Bordeaux, France; Centre de Résonance Magnétique des Systèmes Biologiques, UMR 5536, Université Bordeaux Segalen, Bordeaux, France
| | | | | | | | | |
Collapse
|
32
|
Quantitative biodistribution and pharmacokinetics of multimodal gadolinium-based nanoparticles for lungs using ultrashort TE MRI. MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE 2013; 27:303-16. [PMID: 24170416 DOI: 10.1007/s10334-013-0412-5] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/24/2013] [Revised: 10/09/2013] [Accepted: 10/09/2013] [Indexed: 12/31/2022]
Abstract
OBJECTIVE To study the biodistribution and lung pharmacokinetics of tracheally administered gadolinium-based contrast agents [gadoteric acid and multimodal ultra-small rigid platforms (USRPs)], to validate their pharmacokinetics against optical imaging of fluorescent USRPs, and to test their short-term toxicity. MATERIALS AND METHODS Ultrashort echo-time (UTE) lung proton magnetic resonance imaging (MRI) was performed at 4.7-Tesla (T) after the intratracheal instillation of different concentrations of contrast agent solutions in mice. Pharmacokinetic models were implemented on the absolute concentration calculated from the MRI signal enhancement measurements. Fluorescent USRPs were used to obtain optical images with the same protocol. Bronchoalveolar lavage inflammatory cell count and serum creatinine measurement were performed on four groups of instilled mice (sham, saline, USRPs, lipopolysaccharide). RESULTS MR and optical imaging showed similar kinetics of the USRPs, passing from the airways to the lung tissue and to the kidneys, with negligible hepatic clearance. No significant increase of lung and renal inflammation markers were observed in USRP-instilled animals. CONCLUSION A T 1-weighted radial UTE sequence was found to be valuable in quantitatively monitoring the biodistribution and pharmacokinetics of nanoparticles in the lungs of mice. The observed favorable pharmacokinetics, which was validated by fluorescence imaging, ensures the negligible toxicity of the nanoprobes, making the USRPs and the developed protocol good candidates for applications on selected lung diseases.
Collapse
|
33
|
Lederlin M, Crémillieux Y. Three-dimensional assessment of lung tissue density using a clinical ultrashort echo time at 3 tesla: A feasibility study in healthy subjects. J Magn Reson Imaging 2013; 40:839-47. [DOI: 10.1002/jmri.24429] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2013] [Accepted: 08/27/2013] [Indexed: 11/08/2022] Open
Affiliation(s)
- Mathieu Lederlin
- Centre de Recherche Cardio-Thoracique, Inserm; Université Bordeaux Segalen; Bordeaux France
| | - Yannick Crémillieux
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS; Université Bordeaux Segalen; Bordeaux France
| |
Collapse
|
34
|
Gobbo OL, Zurek M, Tewes F, Ehrhardt C, Crémillieux Y. Manganese: a new contrast agent for lung imaging? CONTRAST MEDIA & MOLECULAR IMAGING 2013; 7:542-6. [PMID: 22991321 DOI: 10.1002/cmmi.1483] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Lung parenchyma remains one of the most difficult tissues to be imaged by means of magnetic resonance imaging (MRI). Several MRI techniques are routinely used for lung imaging. However, manganese-enhancement MRI (MEMRI) technique has not been associated with pulmonary MRI. Here, we evaluated T(1) -enhancement in the rat lung after a manganese instillation, using a 4.7 T magnet with a radial ultrashort echo time sequence. Our data showed that the signal intensity was increased in lungs receiving a manganese solution compared with a control solution to the lungs. MR signal enhancements above 30% were measured in lung parenchyma following 200 µl instillation of a 1 mm manganese chloride solution. MEMRI, therefore, may be a useful novel tool for enhancing signal intensity and image contrast in lung tissue.
Collapse
Affiliation(s)
- Oliviero L Gobbo
- School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland
| | | | | | | | | |
Collapse
|
35
|
Zurek M, Johansson E, Risse F, Alamidi D, Olsson LE, Hockings PD. Accurate T
1
mapping for oxygen-enhanced MRI in the mouse lung using a segmented inversion-recovery ultrashort echo-time sequence. Magn Reson Med 2013; 71:2180-5. [DOI: 10.1002/mrm.24876] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2013] [Revised: 05/24/2013] [Accepted: 06/17/2013] [Indexed: 11/08/2022]
Affiliation(s)
- M. Zurek
- AstraZeneca, Personalized Healthcare and Biomarkers, In vivo Biomarkers; Mölndal Sweden
| | - E. Johansson
- AstraZeneca, Personalized Healthcare and Biomarkers, In vivo Biomarkers; Mölndal Sweden
| | - F. Risse
- AstraZeneca, Personalized Healthcare and Biomarkers, In vivo Biomarkers; Mölndal Sweden
| | - D. Alamidi
- Department of Radiation Physics; Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg; Gothenburg Sweden
| | - L. E. Olsson
- Department of Medical Radiation Physics; IKVM, Lund University; Malmö Sweden
| | - P. D. Hockings
- AstraZeneca, Personalized Healthcare and Biomarkers, In vivo Biomarkers; Mölndal Sweden
- MedTech West; Chalmers University of Technology; Gothenburg Sweden
| |
Collapse
|
36
|
Bianchi A, Lux F, Tillement O, Crémillieux Y. Contrast enhanced lung MRI in mice using ultra-short echo time radial imaging and intratracheally administrated Gd-DOTA-based nanoparticles. Magn Reson Med 2012; 70:1419-26. [PMID: 23233439 DOI: 10.1002/mrm.24580] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2012] [Revised: 10/08/2012] [Accepted: 11/11/2012] [Indexed: 12/20/2022]
Abstract
PURPOSE To investigate the in vivo T1 -enhancement of the lung parenchyma in free-breathing healthy mice following intratracheal administration of Gd-DOTA-based nanoparticles, to assess the enhancement kinetics of the instilled contrast medium and to identify its elimination pathways. METHODS Ultrashort Echo Time (276 μs) proton MRI of the lung was performed (N = 14) at 4.7 T after the intratracheal instillation of 50 μL of seven different concentrations of contrast agent solution (from 2 to 100 mM of Gd(3+) ). The signal enhancement (SE) in lungs, blood, liver, kidneys, and bladder was assessed (N = 3) for a 50 mM concentration solution at different time points. RESULTS The largest SE in lungs (266 ± 14%) was observed for a 50 mM solution of Gd(3+) . In lungs, the SE was observed to decay exponentially with a time constant of 149 ± 51 min. The passage of the nanoparticles from lung tissue to blood and kidneys, and ultimately to the bladder, was observed. No significant hepatic enhancement was measured. CONCLUSION This study demonstrates the feasibility of large SEs of lung tissue using intratracheally administrated solutions of Gd-based contrast agents. In future applications, the SE in lungs could be used to image the biodistribution of coadministrated drug aerosols or to selectively enhance lung diseased tissues.
Collapse
Affiliation(s)
- Andrea Bianchi
- Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, Université Bordeaux Segalen, Bordeaux, France
| | | | | | | |
Collapse
|
37
|
Johnson KM, Fain SB, Schiebler ML, Nagle S. Optimized 3D ultrashort echo time pulmonary MRI. Magn Reson Med 2012; 70:1241-50. [PMID: 23213020 DOI: 10.1002/mrm.24570] [Citation(s) in RCA: 228] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2012] [Revised: 10/09/2012] [Accepted: 10/27/2012] [Indexed: 12/17/2022]
Abstract
PURPOSE To optimize 3D radial ultrashort echo time MRI for high resolution whole-lung imaging. METHODS 3D radial ultrashort echo time was implemented on a 3T scanner to investigate the effects of: (1) limited field-of-view excitation, (2) variable density readouts, and (3) radial oversampling. Improvements in noise performance and spatial resolution were assessed through simulation and phantom studies. Their effects on lung and airway visualization in five healthy male human subjects (mean age 32 years) were compared qualitatively through blinded ordinal scoring by two cardiothoracic radiologists using a nonparametric Friedman test (P < 0.05). Relative signal difference between endobronchial air and adjacent lung tissue, normalized to nearby vessel, was used as a surrogate for lung tissue signal. Quantitative measures were compared using the paired Student's t-test (P < 0.05). Finally, clinical feasibility was investigated in a patient with interstitial fibrosis. RESULTS Simulation and phantom studies showed up to 67% improvement in SNR and reduced blurring for short T2* species using all three optimizations. In vivo images showed decreased artifacts and improved lung tissue and airway visualization both qualitatively and quantitatively. CONCLUSION The use of limited field-of-view excitation, variable readout gradients, and radial oversampling significantly improve the technical quality of 3D radial ultrashort echo time lung images.
Collapse
Affiliation(s)
- Kevin M Johnson
- Department of Medical Physics, University of Wisconsin, Madison, Wisconsin, USA
| | | | | | | |
Collapse
|
38
|
Zurek M, Boyer L, Caramelle P, Boczkowski J, Crémillieux Y. Longitudinal and noninvasive assessment of emphysema evolution in a murine model using proton MRI. Magn Reson Med 2011; 68:898-904. [DOI: 10.1002/mrm.23281] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2011] [Revised: 10/02/2011] [Accepted: 10/11/2011] [Indexed: 11/06/2022]
|
39
|
Alsaid H, Bao W, Rambo MV, Logan GA, Figueroa DJ, Lenhard SC, Kotzer CJ, Burgert ME, Willette RN, Ferrari VA, Jucker BM. Serial MRI characterization of the functional and morphological changes in mouse lung in response to cardiac remodeling following myocardial infarction. Magn Reson Med 2011; 67:191-200. [DOI: 10.1002/mrm.22973] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2010] [Revised: 03/02/2011] [Accepted: 03/30/2011] [Indexed: 11/08/2022]
|
40
|
van Echteld CJA, Beckmann N. A View on Imaging in Drug Research and Development for Respiratory Diseases. J Pharmacol Exp Ther 2011; 337:335-349. [DOI: 10.1124/jpet.110.172635] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/30/2023] Open
|
41
|
Zurek M, Crémillieux Y. MRI of the lung: non-invasive protocols and applications to small animal models of lung disease. Methods Mol Biol 2011; 771:459-474. [PMID: 21874493 DOI: 10.1007/978-1-61779-219-9_24] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Magnetic resonance imaging (MRI) can be used in pre-clinical studies as a non-invasive imaging tool for assessing the morphological and functional impact of lung diseases and for evaluating the efficacy of potential treatments for airways diseases. Hyperpolarized gases ((3)He or (129)Xe) MRI provides insight into the lung ventilation function. Lung proton MRI provides information on lung diseases associated with inflammatory activity or with changes in lung tissue density. These imaging techniques can be implemented with non-invasive protocols appropriate for longitudinal investigations in small animal models of lung diseases. This chapter will detail two (3)He and proton lung MR imaging protocols applied on two models of lung pathology in rodents.
Collapse
|